Evoqua United States - Canada - EN

Evoqua Water Technologies Invests in New Facility in the United Kingdom

New facility to serve as Evoqua's global center of excellence for UV disinfection solutions

PITTSBURGH, PA & WARRINGTON, UK – Evoqua Water Technologies (NYSE: AQUA), a leader in mission-critical water treatment solutions, recently celebrated the opening of its new facility based in Warrington, United Kingdom. The state-of-the-art facility will serve as Evoqua's global center of excellence in developing leading-edge UV disinfection solutions.

The new facility will relocate Evoqua's operations from its previous site in Wigan, UK, and supports the need for expanded facilities to advance future growth plans. The 30,000 square-foot building boasts an expanded footprint to increase manufacturing and research and development capabilities, a dedicated training space, and additional meeting places to encourage employee collaboration. 

Operations will focus on manufacturing Evoqua's ATG® UV product line - environmentally friendly, chemical-free UV disinfection and water treatment systems. The facility will also serve as the Wallace & Tiernan® product distribution and project build site for the United Kingdom market. Evoqua's Wallace & Tiernan brand encompasses premier products for gas chlorination, disinfection, and chemical dosing.

"We are extremely pleased to officially open our new global center of excellence for UV disinfection solutions," said Ron Keating, Evoqua's Chief Executive Officer. "The investment in this facility underscores our commitment to growth and innovation of our disinfection treatment solutions portfolio, strengthening our ability to support our customers globally."

To inaugurate the event, Mr. Keating was joined by Hervé Fages, Evoqua's Executive Vice President and Applied Product Technologies Segment President, and Steffen Lange, Vice President and General Manager of Evoqua's Disinfection Division, for the ceremonial ribbon-cutting event hosted on June 8, 2022.

Evoqua team cutting the ribbon at the grand opening event (L-R): Steffen Lange, VP and General Manager of Evoqua's Disinfection Division, Phil Walsh, Plant Manager, Kelly Van Marle, Senior Quality Control Technician, Ron Keating, Chief Executive Officer, Hervé Fages, Executive Vice President and Applied Product Technologies Segment President, Sean Zyra, Sr. Director of Manufacturing Engineering and Quality, Frans Conradie, Operations Director, and Dave Robinson, Warehouse Supervisor.

About Evoqua Water Technologies

Evoqua Water Technologies is a leading provider of mission critical water and wastewater treatment solutions, offering a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers who value water. Evoqua has worked to protect water, the environment and its employees for more than 100 years, earning a reputation for quality, safety and reliability around the world. Headquartered in Pittsburgh, Pennsylvania, the company operates in more than 150 locations across nine countries. Serving more than 38,000 customers and 200,000 installations worldwide, our employees are united by a common purpose: Transforming Water. Enriching Life®.


DESOTEC, founded in 1990, is the leading European provider of mobile filtration solutions through a unique and circular service concept, which helps protect the planet by enabling clean water, air, and soil. DESOTEC's customer base is constantly growing thanks to a strong focus on 24/7 service and a commitment to design and deliver the best solution in close dialogue with the customer. Through in-depth expertise of industrial applications and continuous investment in mobile filters, reactivation capacity and well-positioned hubs, DESOTEC ensures that the industry can meet the increasing regulations for a better and cleaner environment. Private equity funds managed by Blackstone acquired DESOTEC in 2021. Further information is available at www.desotec.com.

About Blackstone

Blackstone is the world’s largest alternative asset manager. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $951 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, infrastructure, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com.